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ABSTRACT Of the three known ryanodine receptor (RyR) isoforms expressed in muscle, RyR1 and RyR2 have well-defined
roles in contraction. However, studies on mammalian RyR3 have been difficult because of low expression levels relative to
RyR1 or RyR2. Using the herpes simplex virus 1 (HSV-1) helper-free amplicon system, we expressed either RyR1 or RyR3 in
1B5 RyR-deficient myotubes. Western blot analysis revealed that RyR1- or RyR3-transduced cells expressed the appropriate
RyR isoform of the correct molecular mass. Although RyR1 channels exhibited the expected unitary conductance for Cs in
bilayer lipid membranes, 74 of 88 RyR3 channels exhibited pronounced subconductance behavior. Western blot analysis with
an FKBP12/12.6-selective antibody reveals that differences in gating behavior exhibited by RyR1 and RyR3 may be, in part,
the result of lower affinity of RyR3 for FKBP12. In calcium imaging studies, RyR1 restored skeletal-type excitation-contraction
coupling, whereas RyR3 did not. Although RyR3-expressing myotubes were more sensitive to caffeine than those expressing
RyR1, they were much less sensitive to 4-chloro-m-cresol (CMC). In RyR1-expressing cells, regenerative calcium oscillations
were observed in response to caffeine and CMC but were never seen in RyR3-expressing 1B5 cells. In [3H]ryanodine binding
studies, only RyR1 exhibited sensitivity to CMC, but both RyR isoforms responded to caffeine. These functional differences
between RyR1 and RyR3 expressed in a mammalian muscle context may reflect differences in association with accessory
proteins, especially FKBP12, as well as structural differences in modulator binding sites.
INTRODUCTION
Calcium is a key molecule involved in a wide range of
cellular signaling processes. Increases in cytoplasmic cal-
cium levels lead to many diverse cellular responses such as
protein secretion, cell motility, and gene activation. A well-
characterized role attributed to increases in cytoplasmic
calcium is the activation of contraction in striated muscle,
where calcium stored in the sarcoplasmic reticulum (SR) is
released via the activation of the intracellular calcium re-
lease channel, the ryanodine receptor (RyR).
The ryanodine receptor is a large (subunit molecular mass
565 kDa) homotetrameric protein embedded in the SR
membrane. Three RyR isoforms have been discovered,
which are encoded by three separate genes (McPherson and
Campbell, 1993). RyR1 was initially purified and cloned
from skeletal muscle (Pessah et al., 1986; Takeshima et al.,
1989), whereas RyR2 was first characterized in cardiac
muscle (Inui et al., 1987). RyR3 was first discovered in
epithelial cells (Giannini et al., 1992) and brain (Hakamata
et al., 1992), where its cDNA was isolated based on homol-
ogy to the other RyR isoforms.
Both RyR1 and RyR2 play key roles in excitation-con-
traction (e-c) coupling. In this process, depolarization of the
muscle cell is detected by dihydropyridine-sensitive volt-
age-gated calcium channels (dihydropyridine receptors,
DHPRs) in the plasma membrane, which in turn activate the
RyRs present in the SR. Subsequent efflux of calcium
through the activated RyRs triggers muscle contraction. In
contrast, the physiological function of RyR3 is less well
understood, even though this isoform has been detected in
many tissues, including parotid, spleen, esophagus, and
testis (Giannini et al., 1995). RyR3 is often coexpressed
with other RyR isoforms, although RyR3 is usually not the
predominant isoform. For example, in adult bovine dia-
phragm, RyR3 constitutes only 5% of the total [3H]ry-
anodine binding sites (the remainder being RyR1; Jeyaku-
mar et al., 1998), and in most adult mammalian fast twitch
muscle it accounts for only 0–0.2% of the total. An excep-
tion to this finding occurs in adult avian, amphibian, and
fish skeletal muscle (Airey et al., 1990; Olivares et al.,
1991; Lai et al., 1992b), which express approximately equal
levels of the  and  RyR isoforms (homologous to the
RyR1 and RyR3 isoforms, respectively).
Interestingly, RyR3 levels in many different muscle types
often display a distinct developmental profile (Bertocchini
et al., 1997), and in skeletal muscle cell lines RyR3 levels
increase concomitantly with cellular differentiation (Tarroni
et al., 1997). However, the functional consequences of these
expression patterns are not known. In neonatal skeletal
muscle, tension development in response to the RyR agonist
caffeine and contractile force in response to electrical field
stimulation are reduced in transgenic RyR3-deficient mice
(Bertocchini et al., 1997). However, in skeletal muscle from
adult mice lacking RyR3, e-c coupling, calcium-induced
calcium release (CICR), and cell contraction are essentially
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normal compared to wild type (Takeshima et al., 1996;
Bertocchini et al., 1997; Dietze et al., 1998). Recent work
indicates that although the overall level of RyR3 declines
during skeletal muscle maturation, the amount of RyR3 in a
subset of adult skeletal muscle fibers remains at high levels
(Flucher et al., 1999). These results taken together suggest
that while the contribution of RyR3 to adult mammalian
skeletal muscle function is speculative, RyR3 could have an
important accessory role in both neonatal and adult muscle
contraction.
Recent functional studies have described [3H]ryanodine
binding and single-channel behavior of both native and
recombinant RyR3 as well as cellular calcium regulation of
recombinant RyR3. This has been done in one of two ways:
1) by either immunoprecipitation with RyR3-selective an-
tibodies (Murayama and Ogawa, 1997; Jeyakumar et al.,
1998; Murayama et al., 1999) or biochemical isolation from
diaphragm (Sonnleitner et al., 1998), or 2) by transfecting
RyR3 cDNA into mammalian nonmuscle cell lines such as
HEK293 (Chen et al., 1997) or Chinese hamster ovary cells
(Saeki et al., 1998). While this work has provided useful
cellular and molecular information concerning RyR3, the
lack of a skeletal muscle context used in these studies limits
conclusions about its role in skeletal muscle contraction.
We have utilized a new approach, which is to express
RyR1 and RyR3 in the RyR-deficient 1B5 myogenic cell
line (Moore et al., 1998; Protasi et al., 1998). 1B5 cells can
be differentiated into multinucleated myotubes and express
the key triadic proteins, including DHPR, 12-kDa FK506
binding protein (FKBP12), calsequestrin, and triadin, but
are completely deficient in all RyR isoforms, as judged by
ryanodine binding, RyR immunocytochemistry, Western
blot analysis, and fluorescence calcium imaging. In this
study, we report the divergent physiological and pharmaco-
logical properties of RyR1 and RyR3 expressed at compa-
rable levels in 1B5 myotubes, revealing the importance of
both molecular structure and cellular context in defining the
functional phenotype of these RyR isoforms.
MATERIALS AND METHODS
Cell culture
1B5 cells were cultured in growth medium consisting of Dulbecco’s
modified Eagle’s medium (DMEM) containing 100 units/ml penicillin-G,
100 g/ml streptomycin sulfate, 2 mM glutamine, and 20% (v/v) fetal
bovine serum (Gibco Laboratories, Gaithersburg, MD) at 37°C in 10%
CO2 (Moore et al., 1998). For Fura-2 ratio fluorescence imaging measure-
ments, cells were grown in 20% fetal bovine serum-DMEM in collagen-
coated 35-mm or 72-well polystyrene plates (Nalge Nunc International,
Rochester, NY). When the cells reached 50% confluence, they were
stimulated to differentiate into multinucleated myotubes by replacing the
growth medium with DMEM supplemented with 5% (v/v) heat-inactivated
horse serum (Gemini Bio-Products, Calabasas, CA), 2 mM glutamine, and
antibiotics as above. The cells were differentiated at 17.5% CO2, 37°C, for
5–7 days.
C2C12 myoblasts (American Type Culture Collection, Manassas, VA;
Yaffe and Saxel, 1977) were cultured and differentiated as described for
1B5 cells (above), except that C2C12 cells were differentiated at 10% CO2,
37°C, for 5–7 days.
Viral infection
Herpes simplex virus 1 (HSV-1) virions containing the cDNA encoding
either RyR1 or RyR3 were prepared as described previously (Wang et al.,
2000). 1B5 cells differentiated for 5 days were infected with RyR cDNA-
containing helper-free HSV-1 amplicon virions in the presence of antibi-
otic-free 5% heat-inactivated horse serum at 17.5% CO2, 37°C, at 1  10
5
infectious units (IU)/ml after the initial optimization studies were done (see
Results). After 24 h, the virus-containing medium was replaced with
standard differentiation media, and the infected myotubes were incubated
as above for an additional 24 h. These myotubes were then either examined
for calcium responses or fixed for immunohistochemical analysis (see
below).
Immunohistochemistry
Differentiated 1B5 myotubes were fixed in cold methanol (20°C) for 15
min and washed with phosphate-buffered saline (PBS ) (Gibco Laborato-
ries). Cells were then permeabilized with PBS/0.05% Tween-20 for 1 min
before blocking with PBS/5% normal goat serum three times for 10 min
each. Blocking buffer was removed, and anti-RyR1/3 34C monoclonal
antibody (Developmental Studies Hybridoma Bank, University of Iowa,
Iowa City, IA; Airey et al., 1990) was applied at a concentration of 1:25 in
PBS for 1 h at 25°C. Cells were washed with PBS/5% normal goat serum
three times and then incubated with Cy-3-conjugated goat anti-mouse IgG
(1:1000) (Jackson ImmunoResearch Laboratories, West Grive, PA) for 1 h.
The cells were then rinsed three times with PBS and mounted with
Gel/Mount (Biomeda Corp., Foster City, CA). Cy-3 fluorescence was
visualized with a Nikon Diaphot microscope (Nikon, Melville, NY) with
an epifluorescence attachment (510–560 nm excitation, 590 nm emission).
Cell counts
The intracellular distribution of RyR immunolabeling was determined by
examining randomly selected fields from RyR1-infected 1B5 myotubes,
using a 20 lens. Immunolabeled cells were categorized as exhibiting
“reticular,” “punctate,” or “mixed” type immunoreactivity, as defined in
the companion report (Protasi et al., 2000). The relative percentage of cells
displaying these labeling patterns was determined from four 20 fields
from three RyR1-infected 35-mm dishes at two different viral concentra-
tions (1 and 2  105 IU/ml).
Calcium imaging
Differentiated 1B5 myotubes were loaded with the calcium indicator dye
Fura-2 at 37°C, for 20 min in “imaging buffer” (125 mM NaCl, 5 mM KCl,
2 mM KH2PO4, 2 mM CaCl2, 1.2 mM MgSO4, 6 mM glucose, and 25 mM
HEPES, pH 7.4) supplemented with 0.05% bovine serum albumin (fraction
V) and 5 M Fura-2/AM (Molecular Probes, Eugene, OR). The cells were
then washed three times with 1 ml imaging buffer supplemented with 250
M sulfinpyrazone. The cells were transferred to a Nikon Diaphot micro-
scope and Fura-2 was excited alternately at 340 nm and 380 nm, using a
DeltaRam fluorescence imaging system (Photon Technology International,
Princeton, NJ). Fluorescence emission was measured at 510 nm with a 10
quartz objective. Data were collected with an IC-300 intensified CCD
camera (Photon Technology International) from regions consisting of
20–100 individual cells. Image files representing raw fluorescence data
were saved to a hard drive and subsequently analyzed using Imagemaster
software (Photon Technology International). Data presented as the ratio of
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the 510-nm emissions of Fura-2 obtained at 340- and 380-nm excitation
(ratio 340/380) was collected from individual cells.
RyR agonists were dissolved in imaging buffer, and 10 volumes (100
l) was perfused into microtiter wells containing RyR-infected 1B5 myo-
tubes. Electrical field stimulation was accomplished using bipolar solid-
state silver electrodes connected to a Pulsar 4i stimulator (Frederick Haer
and Co., Bowdoinham, ME). The electrodes were placed at the edges of the
field of cells being imaged, and 5-V, 200-ms pulses with a 20-s interpulse
interval were applied.
Membrane preparations
Myotubes infected with RyR cDNA-containing viruses were rinsed two
times with ice-cold PBS and scraped from 100-mm plates in the presence
of 3 ml harvest buffer (137 mM NaCl, 3 mM KCl, 8 mM Na2HPO4, 1.5
mM KH2PO4, 1.5 mM EDTA, pH 7.4). Cells were centrifuged for 5 min
at 100 g, and each cell pellet was resuspended in ice-cold hypotonic lysis
buffer (1 mM EDTA, 1 M leupeptin, 250 M phenylmethylsulfonyl
fluoride, 10 g/ml pepstatin A, 10 g/ml aprotinin, 10 mM HEPES, pH
7.4). The resuspended pellet was homogenized on ice using a PowerGen
700D, for 3 5 s at 1400 rpm (Fisher Scientific, Pittsburgh, PA). An equal
volume of ice-cold 20% sucrose buffer (10 mM HEPES, pH 7.4) was
added, and the tissue was further homogenized as above. This homogenate
was centrifuged at 110,000  g in a Beckman Ti80 rotor (Palo Alto, CA)
for 1 h at 4°C. The pellet was then resuspended in 4 ml of buffer containing
10% sucrose and 10mMHEPES (pH 7.4). The resuspended pellet was divided
into small aliquots, frozen in liquid nitrogen, and stored at80°C until it was
used for binding analysis. For Western blot analysis and single-channel mea-
surements, the membranes were further purified by sedimentation of the crude
membranes at 40,000  g on a sucrose gradient consisting of layers of 10%,
27%, and 45% (w/w) sucrose and 10 mM HEPES (pH 7.4). The 27–45%
interface containing heavy SR membranes was isolated from the gradient,
diluted in 10 mM HEPES (pH 7.4), and pelleted at 110,000  g for 1 h. The
pellet was resuspended in 10% sucrose, 10 mM HEPES (pH 7.4); divided into
small aliquots; and stored at 80°C.
Membranes enriched in markers of junctional SR were prepared from
rabbit fast skeletal muscle, using the method of Saito and co-workers (Saito
et al., 1984) in the presence of 100 M phenylmethylsulfonyl fluoride and
10 g/ml leupeptin. Purified heavy SR from the 38–45% interface of
sucrose density gradients was pelleted, resuspended at 2–6 mg/ml (Lowry
et al., 1951), frozen in liquid nitrogen, and stored at 80°C until needed.
Membranes enriched in cardiac junctional SR were prepared from rabbit
heart, using the method of Feher and co-workers (Feher and Davis, 1991).
Avian junctional SR membranes were isolated from avian pectoralis mus-
cle according to the method of Airey and co-workers (Airey et al., 1990).
Western blot analysis
The methods used for gel electrophoresis and Western blot analysis were
described in detail elsewhere (Moore et al., 1998). Briefly, proteins were
denatured at 100°C for 30 min in reducing sample buffer, which consisted
of 48 mM NaH2PO4, 170 mM Na2HPO4, 0.02% bromophenol blue, 1%
sodium dodecyl sulfate, and 5% -mercaptoethanol (pH 7.4). Protein
(0.5–20 g) was loaded onto 5% sodium dodecyl sulfate-polyacrylamide
gels and electrophoresed at constant voltage (200 V). The size-separated
proteins were transferred onto polyvinylidene difluoride microporous
membranes (Millipore, Bedford, MA), using an electroblotter (Mini Trans-
Blot; Bio-Rad Laboratories, Hercules, CA) overnight at 30 V (4°C) and for
1 h at 200 V. Polyvinylidene difluoride transfers were incubated for 1 h at
25°C in TTBS (137 mM NaCl, 20 mM Tris-HCl, 0.05% Tween 20, pH 7.6)
containing 5% (w/v) nonfat milk. The blots were then probed with either
a primary antibody that recognizes both RyR1 and RyR3 (34C: 1:200
dilution), a RyR2-specific (C3–33: 1:250 dilution, generously provided by
G. Meissner; Lai et al., 1992a) or RyR3-specific (Ab 7165: 1:1000 dilution,
generously provided by Dr. G. Meissner; Protasi et al., 2000) antibody.
Immunophilins FKBP12 and FKBP12.6 were detected using selective
polyclonal antibody PA1–026 (Affinity Bio-Reagents, Golden, CO). The
selected antibody was diluted in TTBS plus 1% bovine serum albumin and
incubated with the blot for 1 h at 25°C. The immunoblots were rinsed three
times with TTBS and then incubated either with a horseradish peroxidase-
conjugated sheep anti-mouse IgG (1:20,000) (for blots probed with 34C or
C3–33) or goat anti-rabbit IgG (1:10,000) (for blots probed with Ab 7165
and PA1–026) (Sigma Chemical Co., St. Louis, MO) for 1 h. After a final
rinse step with TTBS, enhanced chemiluminescence techniques (NEN Life
Science Products, Boston, MA) were used to visualize the immunoblots.
Radioligand binding assay
High-affinity equilibrium binding of [3H]ryanodine (62 Ci/mmol; New
England Nuclear, Boston, MA) to membrane homogenates prepared from
differentiated 1B5 myotubes was performed in the presence of 140–250
mM KCl, 15 mM NaCl, 10% sucrose, 20 mM HEPES (pH 7.1), 1 M
Ca2, and 10 nM [3H]ryanodine. The binding reaction was conducted at
37°C for 3 h in 0.5 ml containing 50 g of whole membrane homogenate
prepared from 1B5 cells. Nonspecific binding was assessed in the presence
10 M unlabeled ryanodine. Pharmacological responses to 4-chloro-m-
cresol (CMC) (50–500 M) and caffeine (200 M to 40 mM) were
examined in the presence of 10 nM [3H]ryanodine and 1 M Ca2.
Separation of bound and free ligand was performed by rapid filtration
through Whatman GF/B glass fiber filters, using a Brandel (Gaithersburg,
MD) cell harvester. Filters were washed with 2 volumes of 5 ml ice-cold
wash buffer containing 20 mM Tris-HCl, 250 mM KCl, 15 mM NaCl, 50
M CaCl2 (pH 7.1) and placed in vials with 5 ml scintillation cocktail
(Ready Safe; Beckman Instruments, Fullerton, CA). The [3H]ryanodine
remaining on the filters was quantified by liquid scintillation spectrometry.
Single-channel measurements
Heavy SR membrane vesicles isolated from RyR1- or RyR3-infected 1B5
cells were fused into a bilayer lipid membrane (BLM) made from a 5:2
mixture of synthetic phosphatidylethanolamine and phosphatidylcholine
suspended at 50 mg/ml in decane. The BLM was formed across a 200–
250-m hole in a polystyrene cup separating two chambers (cis and trans) of
0.7 ml each. Microsomal membrane vesicles (0.1–5 g protein) were added to
the cis chamber in the presence of 200 M Ca2. The cis and trans chambers
contained 500 mM CsCl (or CH3O3SCs), 20 mM HEPES (pH 7.4) and 100
mM CsCl (or CH3O3SCs), 20 mM HEPES (pH 7.4), respectively. After
fusion, 300 MEGTAwas added to the cis chamber to prevent any additional
fusion events. The cis chamber was then perfused with a solution composed of
500 mM CsCl (or CH3O3SCs) and 20 mM HEPES (pH 7.4) (asymmetrical
conditions, 5:1 cis:trans; or symmetrical conditions, 1:1). Single-channel cur-
rent was measured under voltage clamp, using a Dagan 3900 amplifier (Dagan
Instruments, Minneapolis, MN). Holding potentials were with respect to the
trans (ground) chamber, and positive current was defined as current flowing
from cis to trans. Current signals were captured at 10 kHz and filtered at 1 or
2 kHz, using a four-pole Bessel filter. Data were digitized with a Digidata 1200
interface (Axon Instruments, Burlingame, CA) and stored on computer for
subsequent analysis.
Experimental reagents were added to the cis chamber and stirred for
30 s. Subsequent channel gating behavior was recorded for 1–20 min, using
Axotape software (Axon Instruments). Single-channel data from BLM
experiments were analyzed using pCLAMP software (pCLAMP version
7.0; Axon Instruments), and figures were prepared using Origin 5.0 (Mi-
crocal, Northampton, MA).
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RESULTS
Expression of RyR1 and RyR3 protein in
differentiated 1B5 myotubes
Expression of RyR protein in 1B5 myotubes was achieved
using HSV-1 virions that contain the cDNA for either rabbit
RyR1 or RyR3. Increasing amounts of RyR1 cDNA-con-
taining viral particles resulted in a linear increase in the
number of RyR immunoreactive 1B5 cells. At the highest level
of virus tested (4  105 infectious units/ml), 56  9% of the
1B5 cells in randomly selected 20 microscopic fields ex-
pressed RyR1 protein. At an equivalent level of infection,
RyR3 cDNA-containing viruses gave essentially the same
transfection efficiency as viruses containing RyR1 cDNA.
In agreement with our published results (Moore et al.,
1998), no expression of RyRs was detected by Western blot
in untransfected 1B5 myotubes probed with antisera to
RyR1/RyR3 (34C monoclonal; Fig. 1 A, lane 2), RyR2
(C3–33 monoclonal; data not shown), or RyR3 alone (poly-
clonal Ab 7165; Fig. 1 B, lane 4). Western blot analysis of
heavy SR membranes isolated from RyR1- or RyR3-in-
fected 1B5 myotubes revealed each to possess a single
high-molecular-weight protein when probed with 34C, a
monoclonal antibody that recognizes both RyR1 and RyR3
(Fig. 1 A). RyR3 (lane 4) migrated slightly ahead of RyR1
(lane 3), which is in agreement with the lower molecular
weight of RyR3 deduced from its cDNA sequence. The
migration of RyR1 and RyR3 isolated from 1B5 cells was
similar to the migration of RyR1 from rabbit junctional
sarcoplasmic reticulum (JSR; Fig. 1 A, lane 1) and RyR3
from avian skeletal muscle (Fig. 1 B, lane 1), respectively.
In addition, a mixture from separate preparations of either
RyR1- or RyR3-infected 1B5 myotubes yielded a doublet
on the Western blot (Fig. 1 A, lane 5), thus confirming that
the difference in migration of RyR1 and RyR3 reflected
actual differences in protein apparent molecular mass rather
than possible electrophoretic artifacts. Finally, the RyR3-
selective antibody (Fig. 1 B) detected protein from RyR3-
(lane 2) but not RyR1- (lane 3) infected 1B5 myotubes or
from rabbit skeletal muscle JSR (lane 5). The RyR2-selec-
tive antibody (C3–33) did not detect protein from either
RyR1- or RyR3-infected myotubes (data not shown).
Reconstitution of functional RyR responses
Single-channel studies
Further studies were performed with heavy SR membranes
isolated from 1B5 myotubes fused in a BLM to study the
FIGURE 1 Viral transduction of RyR1 or RyR3 cDNAs yields full-length protein in 1B5 myotubes. (A) RyR immunoreactivity was detected using an
anti-RyR1/RyR3 antibody (34C) and visualized using enhanced chemiluminescence as described in Materials and Methods. Lanes were loaded as follows:
Lane 1: Rabbit skeletal muscle JSR (1 g). Lane 2: Control (noninfected) 1B5 cells (20 g). Lane 3: RyR1-infected 1B5 cells (20 g). Lane 4:
RyR3-infected 1B5 cells (20 g). Lane 5: Mixture of extracts prepared from RyR1- and RyR3-infected 1B5 cells (20 g each). Arrows indicate the presence
of the doublet in lane 5 (RyR1, top; RyR3, bottom band). Film was exposed for 10 s for lanes 3–5 and for 3 min for lanes 1 and 2. (B) RyR immunoreactivity
was detected using an anti-RyR3 polyclonal antibody (7165). Lane 1: Avian skeletal muscle JSR (2 g). Lane 2: RyR3-infected 1B5 cells (20 g). Lane
3: RyR1-infected 1B5 cells (20 g). Lane 4: Control (noninfected) 1B5 cells (20 g). Lane 5: Rabbit skeletal muscle JSR (2 g). Film was exposed for
3 min for lane 1 and for 30 s for lanes 2–5. The arrow indicates the position of the RyR3 band in avian skeletal muscle JSR. Note: Increasing the exposure
time to 10 min did not reveal any RyR bands in lanes 3–5.
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gating behavior of virally transduced RyR1 and RyR3 chan-
nels. Of n  60 successful channel fusions, virally trans-
duced recombinant RyR1 exhibited rapid gating kinetics
with a single unitary cesium conductance ranging from 407
to 485 pS. The pharmacological responses of expressed
RyR1 were indistinguishable from those measured from
rabbit skeletal muscle SR. These results are in agreement
with previous findings from experiments using lipo-
fectamine to introduce RyR1 cDNA into 1B5 myotubes
(Moore et al., 1998) and subsequent results for viral infec-
tion (Wang et al., 2000). In contrast, RyR3 channels exhib-
ited stable and frequent transitions to and from subconduc-
tance levels that were most evident at suboptimal (5–10
M) cis Ca2. Fig. 2 A shows a representative RyR3
channel illustrating regular gating transitions from full
closed to 1⁄4 state and then 1⁄4 to full open. Gating transitions
to 1⁄2 and 3⁄4 conductances were also evident in most traces,
although they are somewhat less frequent (Fig. 2 A, inset
showing all-points histogram). Subconductance behavior of
RyR3 reconstituted from 1B5 SR membranes was seen in
FIGURE 2 Sarcoplasmic reticulum enriched in RyR3 exhibits pronounced subconductance behavior when reconstituted in lipid bilayers. (A) Stable
subconductance transitions were apparent (long-lived) when cis Ca2 was 5–10 M and the open probability (Po) was low. This type of gating was observed
in 84% of n  88 RyR3 channels reconstituted and was never seen with transgenic RyR1 channels (n  60 reconstitutions) isolated from 1B5 myotubes
that possessed only the 456  32 pS transition. Inset: All-points histogram of channel trace in A, indicating the relative frequencies of the closed state (C),
the subconductance states (S1, S2, and S3), and the full open state (O). (B) RyR3 channel where the cis [Ca2] was elevated to 200 M. The frequency
and lifetime of full 480-pS open-state transitions was increased, although subconductances were still apparent in the trace and all-points histograms (inset).
See text for details. The holding potential was 20 mV, with 5:1 cis:trans Cs as the current carrier. (C) FKBP12 is enriched in heavy SR membranes
isolated from RyR1-expressing but not RyR3-expressing 1B5 myotubes. Polyclonal antibody PA1-026 selectively recognized human recombinant FKBP12
and FKBP12.6 (lane 1; 10 ng each). Isolated junctional SR from rabbit skeletal muscle contained only FKBP12 (lane 2; 3 g protein). Likewise, the heavy
SR fractions from null 1B5 myotubes were found to contain a low level of FKBP12 (lane 3; 20 g protein). Transduction of 1B5 myotubes with RyR1
cDNA resulted in a significant increase in immunoreactive FKBP12 protein in the same heavy SR fraction enriched in RyR1 protein (lane 4; 20 g protein).
In contrast, SR obtained from RyR3-infected 1B5 myotubes (lane 5, 20 g protein) showed levels of FKBP12 similar to those of SR isolated from null
myotubes. These results were repeated four times with the same results.
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n  74 of 88 channels reconstituted in the BLM. The
remaining 16% (n  14) of RyR3 channels showed little or
no subconductance behavior. In channels exhibiting multi-
ple conductance states, the incidence of subconductance
transitions decreased in the presence of optimal (50–200
M) cis Ca2, and the full open (480 pS) and full closed
transitions predominated (Fig. 2 B). The RyR3 channels
maintained their expected sensitivity to ryanodine and ru-
thenium red, which stabilized a long-lived 1⁄2 conductance
and fully blocked the channel, respectively (data not
shown).
The major T-cell immunophilin FKBP12 has been shown
to tightly bind RyR1 and to colocalize with the channel
complex in isolated SR (Marks, 1996). Heavy SR mem-
branes from null 1B5 myotubes and myotubes transduced
with RyR1 or RyR3 cDNA were probed for their ability to
bind an anti-FKBP12 polyclonal antibody (Fig. 2 C). This
antibody recognized both human recombinant FKBP12 and
FKBP12.6 (lane 1) and FKBP12 associated with junctional
SR isolated from rabbit skeletal muscle (lane 2). FKBP12
but not FKBP12.6 was detected in SR from null 1B5 myo-
tubes (lane 3). The amount of FKBP12 that sedimented with
the heavy SR fraction was significantly higher in prepara-
tions from cells transduced with RyR1 compared with those
transduced with RyR3 (compare lanes 4 and 5). These
results indicate that FKBP12 may be less tightly associated
with RyR3 than with RyR1 and dissociates more readily
from the SR fraction during isolation.
Correlation between immunolabeling and recovery of
RyR function
Using 1B5 cells grown in microtiter plates, it was possible
to directly correlate the recovery of functional responses
with RyR immunoreactivity in individual cells (Fig. 3).
When resting RyR1-infected 1B5 cells loaded with Fura-2
(Fig. 3 A) were stimulated with the RyR agonist 4-chloro-
m-cresol (500 M; Fig. 3 B), the cytosolic ratio of Fura-2
fluorescence (F340/F380) rapidly increased (Fig. 3 D), in-
dicating an elevation in intracellular calcium. Only those
FIGURE 3 Only 1B5 myotubes expressing RyR pro-
tein display functional RyR-dependent calcium re-
sponses. 1B5 cells grown in collagen-coated 72-well
microtiter plates (Terasaki format) were infected with
RyR1 cDNA containing pHSV virions at 2 105 IU/ml.
Cells were examined for calcium responses using Fura-2
as described in Materials and Methods and then fixed
and probed for RyR immunoreactivity, using 34C pri-
mary antibody. (A) F340/F380 ratio of unstimulated 1B5
cells loaded with Fura-2. (B) Cells in A stimulated with
500 M 4-chloro-m-cresol (CMC). Note: An increase in
the brightness of the cells in B indicates an increase in
F340/F380 ratio of Fura-2. (C) The field in A and B,
immunostained with 34C anti-RyR antibody. Note that
cells that are immunopositive for RyR expression also
respond to CMC in B. Each arrowhead in A–C indicates
the same cell in all three panels. (D) Calcium trace of the
cell indicated by the asterisk in A and B. The arrows on
the trace indicate the point in the experiment from which
the images in A and B were taken. Calibration bar: 0.1
340/380 ratio units versus 10 s.
2514 Fessenden et al.
Biophysical Journal 79(5) 2509–2525
cells that exhibited RyR1 immunoreactivity (Fig. 3 C) were
responsive to CMC. In agreement with previous results
(Moore et al., 1998), neither RyR immunoreactivity nor
functional responses to RyR agonists were ever observed in
uninfected 1B5 cells.
Excitation-contraction coupling
Restoration of “skeletal type” e-c coupling was accom-
plished by expressing RyR1 but not RyR3 cDNA in 1B5
myotubes. Myotubes expressing RyR1 protein exhibited
calcium transients in response to direct electrical field stim-
ulation (5 V, 200 ms), chemical depolarization with 40 mM
KCl, or addition of 40 mM caffeine (Fig. 4 A). The trans-
duction efficiency of RyR1 cDNA was estimated based on
recovery of function by determining the percentage of the
total number of Fura-2-loaded cells that responded to 40
mM caffeine. The average responsiveness of RyR1-infected
1B5 myotubes (n 183 cells tested) to 40 mM caffeine was
45  7% (Fig. 4 B). Of these caffeine-responsive cells,
78  7% responded to 40 mM KCl and 18  11% re-
sponded to electrical field stimulation. In contrast, although
36  8% of cells infected with RyR3 cDNA-containing
virus responded to caffeine (Fig. 4, C–D), none of the cells
responded to either electrical or chemical depolarization (0
cells of 187 RyR3-expressing cells).
The percentage of RyR1-expressing 1B5 cells that re-
sponded to the two different modes of depolarization (KCl
FIGURE 4 Excitation-contraction cou-
pling can be reconstituted in RyR1-express-
ing but not in RyR3-expressing 1B5 myo-
tubes. 1B5 myotubes infected with either
RyR1 (A) or RyR3 (C) cDNA-containing vi-
ruses (1  105 IU/ml) or C2C12 myotubes
(E) were imaged for calcium as described in
Materials and Methods. Cells stimulated with
three consecutive 5-V, 200-ms pulses spaced
20 s apart (arrows) were then depolarized for
30 s, using 40 mM KCl (filled bar), and, after
washout, stimulated with 40 mM caffeine for
30 s (unfilled bar). Finally, cells were treated
with 2 M ionomycin (not shown) to obtain
the total number of Fura-2-loaded cells. B, D,
and F summarize calcium responses seen in
RyR1-expressing 1B5 cells (n  86 cells),
RyR3-expressing 1B5 cells (n  49 cells),
and C2C12 cells (n  156), respectively.
Note: % Responding cells indicates the per-
centage of cells responding to an agonist
relative to the total number of Fura-2-loaded
cells. Values represent the mean  SD from
five determinations. Calibration bar for each
trace: 0.05 340/380 ratio units versus 25 s.
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and field stimulation) were quite different. The reason for
this difference was explored using C2C12 cells (Fig. 4,
E–F), which are derived directly from embryonic mouse
skeletal muscle (Yaffe and Saxel, 1977) and thus target
RyRs efficiently to calcium release units (CRUs). Similar to
RyR1-expressing 1B5 cells, C2C12 cells responded to both
electrical and chemical depolarization. Of the total number
of Fura-2-loaded cells, 96  4% responded to 40 mM
caffeine, and of these cells, 87  11% responded to 40 mM
KCl and 20 13% responded to electrical field stimulation.
The percentage of cells responding to electrical field simu-
lation was similar between RyR1-expresssing 1B5 cells and
C2C12 cells (18  11% and 20  13%, respectively) and
was low compared to chemical depolarization with KCl
(78  7% and 87  11%, respectively). Therefore, the
modest level of responsiveness to electrical field stimulation
reflects the relatively low efficiency of this method in
depolarizing myotubes rather than improper intracellular
targeting of RyR1.
The e-c coupling observed in RyR1-expressing 1B5 cells,
like that in C2C12 myotubes was “skeletal type,” inasmuch
as responses to electrical depolarization were independent
of extracellular calcium. Fig. 5 shows a representative
RyR1-transduced 1B5 myotube (Fig. 5 A) and C2C12 myo-
tube (Fig. 5 B), which responded to electrical field stimu-
lation both in the presence of 2 mM extracellular calcium
and in nominally calcium-free medium supplemented with 2
mM EGTA (free [Ca2]  10 nM).
Correlation between RyR1 localization and
restoration of e-c coupling
As described (Protasi et al., 2000), 1B5 cells expressing
either RyR1 or RyR3 give rise to three patterns of immu-
nolabeling, “punctate,” “reticular,” and “mixed.” Punctate
labeling indicates RyRs properly localized to CRUs in the
junctional SR membrane in well-differentiated 1B5 myo-
tubes, whereas reticular labeling represents RyRs that have
not been targeted to junctions and presumably are localized
within the SR/ER lumen. Cells with mixed-type labeling
contain both reticular and punctate labeling patterns. The
percentage of 1B5 cells expressing RyR1 that contained
punctate or mixed RyR1 immunoreactivity was closely cor-
related with the percentage of cells that responded to chem-
ical depolarization with 40 mM KCl. In calcium imaging
studies, as the viral concentration was increased from 1 
105 to 2  105 IU/ml, the number of transduced cells
increased from 47% to 69%. However, the percentage of
RyR1-expressing cells exhibiting e-c coupling decreased
from 78.4% to 50%. In an independent set of parallel
experiments, the immunocytochemical labeling patterns of
RyR1 were examined. These studies revealed that the per-
centage of transduced cells with punctate or mixed RyR1
immunoreactivity decreased from 69% to 48% of the total
number of immunoreactive cells as the viral titer was in-
creased from 1 105 to 2 105 IU/ml. Thus the lower viral
titer was used for all of the remaining studies to optimize the
percentage of cells with proper intracellular targeting of the
expressed RyRs.
RyR1 and RyR3 pharmacology
Ryanodine sensitivity
RyR1 or RyR3 expressed in 1B5 myotubes restored ryan-
odine-induced calcium release (Fig. 6). The effect of 200
M ryanodine added to individual myotubes expressing
transduced RyRs was to gradually raise intracellular Ca2
over several minutes (Fig. 6, A and B). These effects were
FIGURE 5 Recovery of “skeletal-type” e-c coupling in RyR1-express-
ing 1B5 myotubes. 1B5 myotubes infected with viruses containing RyR1
cDNA (1  105 IU/ml) or C2C12 myotubes were imaged for calcium as
described in Materials and Methods. A representative traces from a RyR1-
transduced 1B5 myotube and a C2C12 myotube are shown in A and B,
respectively. The myotubes were stimulated with three consecutive elec-
trical pulses (arrows) as described in Fig. 4. After a 1-min incubation
period in nominally calcium-free imaging buffer supplemented with 2 mM
EGTA (stippled bar), cells were challenged again with electrical pulses and
then with 40 mM caffeine (filled bar). Calibration bar: 0.05 340/380 ratio
units versus 25 s.
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indistinguishable from the actions of ryanodine on C2C12
myotubes (Fig. 6 C).
Caffeine sensitivity
The caffeine sensitivity of C2C12 cells and 1B5 cells ex-
pressing either RyR1 or RyR3 was determined using cal-
cium imaging of individual myotubes. The dose-response
relationship for caffeine was very steep in any given myo-
tube because of a strong component of CICR. Furthermore,
in C2C12 cells, or in 1B5 cells expressing RyR1 or RyR3,
the magnitude of the calcium increase at threshold caffeine
levels was similar to responses seen at maximum caffeine
levels (40 mM), which also strongly suggests a component
of CICR in the caffeine response. This “all or none” re-
sponse in any given cell has also been observed in isolated
mouse myotubes stimulated with 4-chloro-m-cresol (Gsch-
wend et al., 1999).
However, myotubes exhibited a typical threshold for
CICR, and the number of RyR-expressing 1B5 cells re-
sponding increased as the caffeine concentration was in-
creased (Fig. 7 D). Given the steepness of the caffeine
dose-response curve and possible nonlinearity of the fura 2
dye at caffeine concentrations inducing near-saturating in-
tracellular Ca2, the threshold response (not the EC50) was
a more sensitive measure of the inherent sensitivity of the
two RyR isoforms to this activator. For example, the C2C12
cell depicted in Fig. 7 A and the RyR1-transduced 1B5 cell
in Fig. 7 B each had a threshold of 3 mM caffeine. In these
cells, regenerative calcium oscillations were elicited with
submaximum concentrations of caffeine, whereas at high
caffeine concentrations, a sustained calcium increase was
observed. In contrast, RyR3-expressing 1B5 cells typically
had a lower caffeine threshold, such as the cell shown in
Fig. 7 C (threshold of 0.3 mM). However, regenerative
calcium oscillations were never observed in response to
submaximum caffeine concentrations in RyR3-expressing
1B5 cells (also see Fig. 10). Thus two new observations are
that although RyR3 has significantly higher sensitivity to
caffeine compared with RyR1, only RyR1 can support re-
generative oscillations in 1B5 myotubes.
4-Chloro-m-cresol sensitivity
Both C2C12 cells and RyR1-expressing 1B5 cells re-
sponded to CMC (Fig. 8, A and B). Similar to responses to
caffeine, subthreshold concentrations of CMC elicited re-
generative calcium oscillations in both cell types. 1B5 cells
infected with RyR3-containing viruses exhibited a much
lower frequency of responses to CMC compared with
RyR1-expressing myotubes (Fig. 8 C). Whereas all RyR1-
expressing cells that responded to 40 mM caffeine also
responded to 100 M CMC, only 28.8  3.5% of RyR3-
expressing 1B5 cells that responded to caffeine responded
to 500 M CMC (the highest concentration of CMC tested)
(Fig. 8 D).
To provide a biochemical correlation to differences in
sensitivity of RyR1 and RyR3 to RyR agonists, [3H]ryano-
dine binding analysis was performed on total membrane
homogenates isolated from RyR1- or RyR3-expressing 1B5
myotubes under identical assay conditions. When assayed
in the presence of 20–50 M Ca2, the two receptor iso-
forms exhibited saturable binding in the range of 1–50 nM
[3H]ryanodine and gave similar binding constants. The ap-
FIGURE 6 RyR1- and RyR3-expressing 1B5 myotubes respond to ry-
anodine. Cells were cultured and imaged for calcium as described in
Materials and Methods. 1B5 cells expressing either RyR1 (A) or RyR3 (B)
as well as C2C12 myotubes (C) were challenged with 40 mM caffeine
(black bar) followed (after washout) by a 30-min exposure to 200 M
ryanodine (empty bar). In all three cases, ryanodine exposure resulted in a
slow increase in the level of intracellular calcium. Calibration bar: 0.1
340/380 ratio units versus 200 s.
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parent higher caffeine sensitivity of RyR3 in intact 1B5
myotubes did not carry over as an increased caffeine sen-
sitivity in [3H]ryanodine binding studies. In these experi-
ments, caffeine enhanced the occupancy of [3H]ryanodine
binding to RyR1- and RyR3-expressing membranes in a
similar dose-dependent manner (Fig. 9 A). The difference in
CMC sensitivity between RyR1 and RyR3 was confirmed in
[3H]ryanodine binding studies. Fig. 9 B shows that although
CMC increased the binding of [3H]ryanodine to RyR1 in a
dose-dependent manner, saturating at 100% of optimal con-
trol (measured in the presence of 100 M Ca2), the drug
exhibited little efficacy in stimulating ryanodine binding to
RyR3.
Calcium waves
Submaximum levels of caffeine or CMC often triggered
calcium oscillations in C2C12 cells and RyR1-expressing
1B5 cells. These oscillations originated at a specific region
or “trigger zone” in RyR1-expressing 1B5 cells and then
propagated as a discrete calcium wave across the cell (Fig.
10 A). These oscillations persisted as long as the agonist was
present but terminated immediately after the agonist was
removed (Fig. 10 C). However, suprathreshold levels of
caffeine (40 mM; Fig. 10, B and D) or CMC (500 M)
triggered a global increase in calcium in these cells. In
contrast, RyR3-expressing 1B5 cells never displayed cal-
FIGURE 7 RyR1 and RyR3 exhibit different sensitivities to caffeine. Cells were cultured and then imaged for calcium as described in Materials and
Methods. Cells were incubated in increasing caffeine concentrations which ranged from 0.1 to 40 mM. Each caffeine incubation period was 60 s; these were
separated by 60-s recovery periods. (A) Representative trace from a C2C12 cell. Note the presence of calcium oscillations at 3 mM caffeine (asterisk). (B)
Representative trace from a RyR1-expressing 1B5 cell. Calcium oscillations are seen in this cell from 3–10 mM caffeine (asterisks). (C) Representative
trace from a RyR3-expressing 1B5 cell. No calcium oscillations are observed. (D) Summary of caffeine dose-response curves obtained from four separate
determinations. Responses are normalized to the total number of cells responding to 40 mM caffeine, which is taken to represent the total number of
RyR-expressing cells in the field. The number of cells expressing RyR1 and RyR3 analyzed was 67 and 49, respectively. Each point represents a mean 
SD. Inset: RyR3 has a lower threshold caffeine concentration required for activation. The percentage of either RyR1- (open bars) or RyR3- (filled bars)
expressing myotubes with a threshold caffeine concentration between 0.1 and 0.7 mM is indicated. Calibration bar: 0.05 340/380 ratio units versus 50 s.
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cium oscillations when challenged with any concentration
of caffeine. Instead, calcium increases caused by 0.1–4 mM
caffeine were observed in small, localized, cellular regions
that failed to initiate a calcium wave (Fig. 10 E). At higher
caffeine concentrations (5–40 mM), global rises in calcium
were observed in all 1B5 myotubes expressing RyR3 (Fig.
10, F and G).
DISCUSSION
The results reported in this study indicate that several func-
tional differences exist between RyR1 and RyR3 expressed
in 1B5 myotubes. First, only RyR1 can restore depolariza-
tion-induced e-c coupling. Second, there are significant
differences in the sensitivity to caffeine and CMC of cells
expressing RyR1 and RyR3. Third, the type of calcium
release events triggered by caffeine and CMC from these
two ryanodine receptors is fundamentally different: RyR1
supports regenerative calcium oscillations in response to
submaximum doses of caffeine and CMC, whereas RyR3
does not. Finally, the divergent phenotype of RyR1 and
RyR3 appears to be the result of essential protein-protein
interactions within the context of a skeletal muscle environ-
ment (e-c coupling, Ca2 oscillations, and caffeine sensi-
tivity) as well as fundamental structural differences in drug
recognition sites (CMC).
FIGURE 8 RyR1 and RyR3 exhibit differential sensitivity to 4-chloro-m-cresol. 1B5 myotubes were cultured and then imaged for calcium as described
in Materials and Methods. Cells were first challenged with 40 mM caffeine to determine the number of RyR-expressing cells in the field. Cells were then
incubated in increasing CMC concentrations that ranged from 1 to 500 M. Each CMC incubation period was 60 s; these were separated by 60-s recovery
periods. (A) Representative trace from a C2C12 cell. Calcium oscillations are observed at 100 and 200 M CMC (asterisks). (B) Representative trace from
a RyR1-expressing 1B5 cell. Calcium oscillations are observed at 50 and 100 M CMC (asterisks). (C) Representative trace from a RyR3-expressing 1B5
cell. No responses to CMC are observed. (D) Summary of CMC dose-response curves obtained from four separate determinations. Responses are
normalized to the total number of cells responding to the initial application of 40 mM caffeine, which represents the total number of RyR-expressing cells
in the field. The number of cells analyzed that expressed RyR1 or RyR3 was 104 and 71, respectively. Each point represents the mean  SD. Calibration
bar  0.05 340/380 ratio units versus 50 s.
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Expression system
The use of helper-free HSV-1 amplicon virions containing
RyR cDNAs (Wang et al., 2000) has greatly enhanced the
efficiency of RyR expression in 1B5 myotubes. At the
highest level of RyR1 virus tested (2  105 IU/ml), 69% of
1B5 myotubes expressed functional RyR1 receptor (as
judged by the percentage of infected cells responding to 40
mM caffeine). With increasing virus concentration, we ob-
served a linear increase in the number of RyR1-expressing
cells. However, as the number of transduced cells increased,
the percentage of RyR1-expressing cells with a “punctate”
labeling pattern decreased. As discussed (Protasi et al.,
2000), the “punctate” immunolabeling pattern most likely
represents the proper targeting of RyR1 to CRUs. This
concept is supported by our observation that the recovery of
depolarization-induced calcium release was correlated with
the percentage of “punctate” immunolabeled cells. Taken
together, these findings suggest that proper targeting to
CRUs enables RyR1 to couple with the DHPR and restores
e-c coupling. That the relative proportion of 1B5 cells
containing properly targeted RyR1 decreases as viral titer
increases may be due to the increased transduction of less
differentiated cells that do not possess the necessary sub-
cellular organization to target RyR1 correctly to the junc-
tions. At lower viral titers, the transduction of well-differ-
entiated multinucleated myotubes is favored, based on their
larger size and corresponding larger surface area. This in-
terpretation is also supported by our recent findings ob-
tained with a green fluorescent protein amplicon, which
FIGURE 9 Caffeine and 4-chloro-m-cresol have
divergent effects on [3H]ryanodine binding to RyR1
and RyR3. [3H]Ryanodine binding to microsomal
membranes isolated from RyR1- or RyR3-transfected
1B5 cells was measured as described in Materials and
Methods. Results represent the average of two deter-
minations, using [3H]ryanodine  10 nM and
[Ca2]free  1 M. Ryanodine binding in these
conditions in the absence of RyR agonists was 270
and 89 fmol [3H]ryanodine bound/mg protein for
RyR1 and RyR3, respectively, which represents 0%
activation on the graph. Results are normalized to the
level of ryanodine binding achieved at optimal cal-
cium conditions ([Ca2]free  100 M), which is
taken to represent 100% activation. The amount of
[3H]ryanodine bound at this optimal calcium level
was 890 and 416 fmol [3H]ryanodine bound/mg pro-
tein for RyR1 and RyR3, respectively. The effects of
increasing levels of caffeine (A) or 4-chloro-m-cresol
(B) on [3H]ryanodine binding to RyR1 or RyR3 are
indicated.
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revealed more efficient transduction of fully differentiated
1B5 myotubes compared to myoblasts (Wang et al., 2000).
In the present study, functional responses were examined
in 1B5 myotubes infected with a viral titer that ensured the
highest incidence of “punctate” immunolabeling. Although
this approach resulted in a lower than maximum transduc-
tion efficiency, it permitted us to have a more direct com-
parison of functional characteristics exhibited by RyR1 and
RyR3 that were properly targeted to junctions and expressed
at similar levels.
Heterogeneity of RyR1 functional responses
1B5 cells undergo a series of structural changes during
differentiation. Upon withdrawal of serum and an increase
in the ambient CO2 level, 1B5 myoblasts fuse and form
elongated multinucleated myotubes. As documented previ-
ously (Protasi et al., 1998), a structural reorganization of
triadic proteins occurs concomitantly with differentiation,
whereby triadin and DHPRs are organized into discrete foci
at the cell surface (CRUs). However, the differentiation
FIGURE 10 RyR1 but not RyR3 supports regenerative calcium oscillations. Cells were cultured and imaged for calcium as described in Materials and
Methods. Each panel represents a single F340/F380 ratio image; images are spaced 2 s apart. The calibration bar for these images is indicated at the bottom
of the figure. (A) Ratio images from a 1B5 myotube expressing RyR1 stimulated with 3 mM caffeine are shown. After 2 s, a calcium wave begins from
a discrete region and spreads across the cell. After 2 s more, the calcium wave occurs again. (B) Ratio images from the same cell in A stimulated with
40 mM caffeine. (C) The corresponding change in the Fura-2 340/380 ratio induced by 3 mM caffeine. (D) The corresponding change in the fura-2 340/380
ratio induced by 40 mM caffeine. Calcium increases globally throughout the cell, and no calcium waves or oscillations are observed. Calibration bar for
calcium traces: 0.1 340/380 ratio units versus 10 s. (E) Ratio images from a 1B5 cell expressing RyR3 stimulated with 0.3 mM caffeine. (F) Ratio images
from the cell in E, simulated with 40 mM caffeine. A larger area of the cell responds, but no calcium waves or oscillations are observed (G, solid line).
(G) A calcium increase is observed in a small discrete region of the cell (arrow), but no oscillations are generated, as indicated by the trace (dashed line).
Calibration bar for calcium traces: 0.05 340/380 ratio units versus 10 s.
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process is never complete; i.e., not all 1B5 myoblasts fuse
into myotubes with well-defined CRUs. Thus, when differ-
entiated 1B5 cells are infected with RyR-containing virions,
both fully and partially differentiated 1B5 cells express
RyRs. This concept is important in understanding the func-
tional heterogeneity of RyR-expressing 1B5 cells. We have
observed essentially two populations of 1B5 cells express-
ing RyR1. Of the cells infected at the lower viral titer,
approximately 50% of the cells respond to cellular depolar-
ization with skeletal type e-c coupling and to chemical
agents that directly activate the RyR1 complex, such as
caffeine and CMC. The remaining 50% of the cells respond
solely to these direct chemical agonists. There is excellent
quantitative agreement between the functional phenotypes
reported in the present study and the frequency of cells
exhibiting RyRs properly targeted to CRUs reported in the
companion paper (table 1 in Protasi et al., 2000). Taken
together, these findings strongly suggest that it is the fully
differentiated myotubes possessing mature CRUs that ex-
hibit both skeletal e-c coupling and pharmacological re-
sponsiveness. Cells that respond only to caffeine and CMC
are likely to represent morphologically immature myotubes
that lack CRUs.
Excitation-contraction coupling
1B5 cells share similar characteristics with skeletal muscle,
such as the ability to differentiate into multinucleated myo-
tubes that form dyadic and triadic junctions between the SR
membrane and the cell surface (Protasi et al., 1998). In
addition, 1B5 myotubes express key proteins that are
present at the junction, including triadin, calsequestrin,
FKBP12, the sarco(endo)plasmic calcium ATPase, and
DHPR (Moore et al., 1998). Finally, differentiated 1B5
myotubes develop ordered foci or clusters of colocalized
DHPR and triadin, which presumably correspond to CRUs
(Protasi et al., 1998). Thus these cells contain not only the
component proteins necessary for e-c coupling, but also the
elegant subcellular organization required for this specialized
form of signal transduction.
Upon introduction of the rabbit RyR1 cDNA, depolariza-
tion-induced calcium release (e-c coupling) is restored in
1B5 myotubes. Both chemical depolarization (using 40 mM
KCl) and electrical field stimulation elicit Ca2 transients in
RyR1-transduced 1B5 cells. The relative proportion of cells
exhibiting e-c coupling is essentially identical to the number
of cells that contain punctate intracellular labeling. These
findings strongly suggest that proper targeting of RyR1 to
the junctions is necessary for the restoration of e-c coupling
by RyR1. The difference in the frequency of responses
elicited by K and electrical field stimulation was similar in
transduced 1B5 myotubes and C2C12 myotubes and pri-
marily reflects a lack of efficiency in the delivery of field
stimulation rather than being related to the structure or
function of the CRUs.
Concomitant with this functional restoration of e-c cou-
pling is the ultrastructural localization of RyR1 within 1B5
junctions. As demonstrated (Protasi et al., 2000), RyR1
expression leads to the appearance of feet at SR-plasma
membrane junctions, and foci of RyR1 colocalize with
DHPR foci in the same cells. In addition, RyR1 expression
leads to the formation of well-ordered tetradic arrays of
DHPRs with spacing equal to twice the spacing of feet
along the SR membrane.
In contrast, RyR3 does not restore e-c coupling in 1B5
myotubes and displays a higher frequency of subconduc-
tance transition than does RyR1 when reconstituted in
BLM. The divergent phenotype at the cellular level does not
stem from improper targeting of the RyR3 protein, because
electron micrographs of negatively stained thin sections
clearly show that RyR1 and RyR3 are equally capable of
targeting to junctions and forming arrays of feet (figure 6 in
Protasi et al., 2000) when expressed in 1B5 myotubes at
comparable levels. The present findings extend previous
work demonstrating a lack of e-c coupling in skeletal mus-
cle isolated from RyR1-deficient mice, where RyR3 is ex-
pressed at very low levels (Ivanenko et al., 1995; Takeshima
et al., 1995; Nakai et al., 1996). Furthermore, the crooked
neck chicken lacks expression of RyR (equivalent to mam-
malian RyR1) and e-c coupling despite high levels of RyR
expression (equivalent to mammalian RyR3; Ivanenko et
al., 1995). The most probable explanation for the lack of e-c
coupling in RyR3-expressing 1B5 myotubes is that RyR3
cannot form the necessary functional contacts with DHPR.
Therefore the DHPR cannot provide orthograde activation
of RyR3, nor can it receive retrograde activation from RyR3
to increase calcium influx through the DHPR (Nakai et al.,
1996), which could then activate RyR3 via CICR. Comple-
mentary evidence for this conclusion exists at the ultrastruc-
tural level. As documented by Protasi and co-workers (Pro-
tasi et al., 2000), although RyR3 is targeted appropriately to
the junctions, it lacks the ability to order DHPR clusters into
the tetradic arrays that are seen when RyR1 is expressed.
Therefore, a likely explanation for the lack of e-c coupling
observed when RyR3 is expressed is that this protein does
not or cannot form functional contacts with the 1 subunit
of the DHPR and thus membrane depolarization cannot be
translated into release of SR calcium. Whether RyR3 par-
ticipates in normal skeletal muscle e-c coupling via the
propagation of the calcium signal generated by RyR1 as has
been suggested (Bertocchini et al., 1997) is still a matter of
debate.
RyR3 interactions with FKBP12
Another divergence between RyR1 and RyR3 identified in
the present study is the higher incidence of subconductance
transitions observed with RyR3 reconstituted in BLM,
which were especially prominent at suboptimal Ca2 in the
cis chamber. Using essentially the same RyR3 cDNA con-
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struct to transfect HEK293 cells, Chen and co-workers
(Chen et al. 1997) did not observe prominent subconduc-
tance behavior with purified heterologously expressed
RyR3. Furthermore, -RyR purified from frog muscle by
immunoprecipitation also did not appear to exhibit subcon-
ductance behavior in BLM studies (Murayama et al. 1997,
1999). One possibility for the divergent behavior of RyR3 in
BLM measurements made in the present study is that the
protein was improperly targeted to or folded within SR. This
is highly unlikely, because electron micrographs of thin
sections of 1B5 myotubes expressing RyR1 or RyR3 reveal
junctional localization that is essentially indistinguishable
(figure 6 in Protasi et al., 2000). Furthermore, other essen-
tial elements functionally attributable to RyR3 can be dem-
onstrated at the cellular and single-channel levels (including
activation by Ca2 and caffeine, high-affinity binding of
[3H]ryanodine, and a predictable failure to recover e-c cou-
pling; see below). A second explanation for the subconduc-
tance behavior seen in the present study is the source and
nature of RyR3 used in BLM measurements. In this regard,
two notable differences from the aforementioned studies are
1) the skeletal muscle context in which mammalian RyR3
was expressed and 2) the fusion of RyR3 within native SR
vesicles (as opposed to solubilized purified RyR3). Inter-
estingly, a recent study of RyR3 isolated from bovine dia-
phragm was deemed to exhibit occasional subconductance
transitions, although frequent transitions to the 1⁄4 and 1⁄2
levels were conspicuous in the traces provided (Jeyakumar
et al., 1998; see Figs. 5 and 7). Therefore the subconduc-
tance behavior for mammalian RyR3 expressed within a
skeletal muscle context reported here is not a precedent, but
is more easily discerned because of the stability of the
transitions.
FKBP12, the major T-cell immunophilin, tightly associ-
ates with RyR1 with a stoichiometry of four per channel
oligomer (Timerman et al., 1993). The present work reveals
that heavy SR isolated from 1B5 myotubes possesses sig-
nificantly higher levels of FKBP12 when RyR1 protein is
expressed compared with membranes expressing a similar
density of RyR3. These results strongly suggest that RyR3
may have a lower affinity for FKBP12 than does RyR1 and
is lost during the isolation of the RyR3-enriched SR fraction
by sucrose-gradient sedimentation. Dissociation of FKBP12
from RyR3 during the preparation of SR vesicles may
account for the unique subconductance behavior of RyR3
that we observed in single-channel studies. Consistent with
this interpretation, the immunosuppressant FK506 dissoci-
ates FKBP12 from RyR1, resulting in channels that conduct
current with multiple subconductance states (Timerman et
al., 1993; Brillantes et al., 1994). Although no direct mea-
sures of the relative affinity of FKBP12 or 12.6 for RyR3
are currently found in the literature, the hypothesis that
RyR1 and RyR3 may have different affinities for FKBP12
is not unlikely, because RyR1 and RyR2 isoforms are
known to differ in their binding interactions with FKBP12
and 12.6 (Barg et al., 1997; Xin et al., 1999).
Responses to caffeine and 4-chloro-m-cresol
While the intracellular caffeine dose-response relationship
between RyR1 and RyR3 has not been well characterized,
several reports have examined the sensitivity of RyR3 to
activation by Ca2 at high-affinity cation sites and inhibi-
tion by Ca2 and Mg2 at low-affinity sites (Chen et al.,
1997; Murayama and Ogawa, 1997; Murayama et al.,
1999). Immunopurified RyR3 isolated from diaphragm ap-
pears to be less sensitive to activation by extravesicular
Ca2 in [3H]ryanodine binding studies than is RyR1. If
Ca2 and caffeine sensitivity are controlled through alloste-
ric, mutually interacting sites on the RyR oligomers, one
might expect RyR3 to be less sensitive to caffeine. Our
results in intact 1B5 myotubes, however, indicate the op-
posite. Individual myotubes expressing RyR3 have a higher
sensitivity to caffeine than RyR1-expressing myotubes,
based on the threshold caffeine concentration required to
elicit a full cellular response. There are several possible
explanations for this observation. First, the affinity for caf-
feine for its binding site on RyR3 may be greater than it
affinity for RyR1, thus giving rise to a lower threshold
caffeine concentration required for activation. This possi-
bility is unlikely, however, since, in isolated 1B5 SR prep-
arations, caffeine is equally potent in activating [3H]ryano-
dine binding of both RyR1 and RyR3. A more likely
explanation is that, although the two isoforms have similar
affinities for caffeine, the efficacy with which bound caf-
feine activates the Ca2 release differs. A difference in
efficacy observed for caffeine is likely the result of funda-
mentally different protein-protein interactions between RyR
isoforms and accessory proteins at CRUs within the myo-
tube.
Differences in the affinity of RyR1 or RyR3 for the
accessory protein FKBP12 may mediate differences in sen-
sitivity to caffeine. In intact skeletal muscle, disruption of
the FKBP12/RyR1 complex with FK506 enhances the sen-
sitivity of fibers to depolarization and caffeine (Lamb and
Stephenson, 1996; Lamb, 1997). In our model system, the
observation of increased caffeine sensitivity in RyR3-ex-
pressing 1B5 cells coupled with subconductance behavior
of isolated RyR3 channels suggests that an altered interac-
tion between RyR3 and FKBP12 may lead to heightened
caffeine sensitivity in intact cells.
Another significant difference between RyR1 and RyR3
is the apparent lack of responsiveness of RyR3 to 4-chloro-
m-cresol (CMC). CMC activates RyR1 in both isolated
skeletal muscle vesicles and intact skeletal muscle (Zorzato
et al., 1993; Herrmann-Frank et al., 1996; Tegazzin et al.,
1996; Westerblad et al., 1998; Struk and Melzer, 1999),
although no reports have assessed the effect of CMC on
RyR3. Our results indicate that RyR3-expressing cells are
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very insensitive to CMC, and this insensitivity extends to
isolated SR, where CMC has negligible effects on [3H]ry-
anodine binding. This finding represents a large deviation
from the potent activating effects of CMC on both RyR1-
expressing 1B5 cells and C2C12 cells. Thus the RyR1
protomer may contain a CMC recognition site that either is
absent or is of very low affinity in RyR3. Alternatively,
RyR1 may interact with an accessory protein that itself
binds CMC, but RyR3 may be incapable of this interaction.
Agonist-stimulated cellular calcium responses
At suprathreshold concentrations of caffeine, the spatial
aspects of calcium release by RyR1 and RyR3 appeared the
same: both isoforms exhibited a sustained global increase in
intracellular calcium that resolved after caffeine washout.
However, the nature of the calcium responses to submaxi-
mum concentrations of caffeine seen in RyR1- and RyR3-
expressing cells differed substantially. At submaximum lev-
els of caffeine and CMC, regenerative calcium oscillations
were observed in C2C12- and RyR1-expressing 1B5 myo-
tubes, which were similar to caffeine-induced calcium os-
cillations previously observed in skeletal muscle (Flucher
and Andrews, 1993) and C2C12 cells (Lorenzon et al.,
1997). On the other hand, in RyR3-transduced cells, sub-
maximum concentrations of caffeine produced small, local-
ized increases in intracellular Ca2 that were not propagated
and resolved rapidly.
The different cellular responses of RyR1 and RyR3 to
caffeine may be due to the divergent effects of calcium on
the two isoforms. Single-channel studies have indicated that
micromolar levels of calcium activate RyR3 fully, whereas
the same level of calcium can only partially activate RyR1
(Chen et al., 1997; Murayama et al., 1999). In addition,
isolated RyR3 channels are much less susceptible to cal-
cium inactivation than are RyR1 channels. When translated
to a cellular context, these findings would suggest that when
a RyR3 channel is stimulated by caffeine it would be open
fully and would tend not to inactivate as readily as RyR1.
This activity would discourage calcium oscillations that
require repetitive activation and inactivation of the receptor.
For RyR1, threshold amounts of caffeine or CMC would
partially activate the receptor. As the local calcium level
around the channel increased, adjacent RyRs activated by
CICR would propagate a calcium wave across the cell,
whereas the initiating RyRs would be inactivated by the
heightened local calcium concentration. The process would
repeat itself because of the continued presence of agonist
and the subsequent reactivation of the initiating RyRs. In
both RyR1- and RyR3-expressing cells, suprathreshold lev-
els of agonist would activate most RyRs throughout the cell
and thus result in a global calcium increase.
In summary, RyR1 and RyR3 expressed in 1B5 myotubes
differ in a number of properties, even though these proteins
are processed and targeted similarly (see also Protasi et al.,
2000). The inability of RyR3 to restore depolarization-
induced calcium release provides a functional correlation to
its inability to induce DHPR tetrad formation. In addition,
RyR3 derived from 1B5 cells has pharmacological proper-
ties that are different from those of RyR1 and have not been
observed previously. The present results reveal the impor-
tance of cellular context when RyR structure function is
studied.
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